位置:首页 > 蛋白库 > A1K_LOXRE
A1K_LOXRE
ID   A1K_LOXRE               Reviewed;         279 AA.
AC   Q5YD75;
DT   06-MAR-2007, integrated into UniProtKB/Swiss-Prot.
DT   23-NOV-2004, sequence version 1.
DT   03-AUG-2022, entry version 64.
DE   RecName: Full=Dermonecrotic toxin LrSicTox-alphaIB1;
DE            EC=4.6.1.- {ECO:0000250|UniProtKB:Q4ZFU2};
DE   AltName: Full=Lr1 {ECO:0000303|PubMed:16759681};
DE   AltName: Full=Phospholipase D;
DE            Short=PLD;
DE   AltName: Full=Sphingomyelin phosphodiesterase D 1;
DE            Short=SMD 1;
DE            Short=SMase D 1;
DE            Short=Sphingomyelinase D 1;
OS   Loxosceles reclusa (Brown recluse spider).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida; Araneae;
OC   Araneomorphae; Haplogynae; Scytodoidea; Sicariidae; Loxosceles.
OX   NCBI_TaxID=6921;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Venom gland;
RX   PubMed=15450925; DOI=10.1016/j.toxicon.2004.06.013;
RA   Ramos-Cerrillo B., Olvera A., Odell G.V., Zamudio F., Paniagua-Solis J.,
RA   Alagon A., Stock R.P.;
RT   "Genetic and enzymatic characterization of sphingomyelinase D isoforms from
RT   the North American fiddleback spiders Loxosceles boneti and Loxosceles
RT   reclusa.";
RL   Toxicon 44:507-514(2004).
RN   [2]
RP   FUNCTION, TOXIC DOSE, AND CATALYTIC ACTIVITY.
RX   PubMed=16759681; DOI=10.1016/j.toxicon.2006.04.010;
RA   Olvera A., Ramos-Cerrillo B., Estevez J., Clement H., de Roodt A.,
RA   Paniagua-Solis J., Vazquez H., Zavaleta A., Arruz M.S., Stock R.P.,
RA   Alagon A.;
RT   "North and south american Loxosceles spiders: development of a polyvalent
RT   antivenom with recombinant sphingomyelinases D as antigens.";
RL   Toxicon 48:64-74(2006).
CC   -!- FUNCTION: Dermonecrotic toxins cleave the phosphodiester linkage
CC       between the phosphate and headgroup of certain phospholipids
CC       (sphingolipid and lysolipid substrates), forming an alcohol (often
CC       choline) and a cyclic phosphate (By similarity). This toxin acts on
CC       sphingomyelin (SM) with high activity (18.3 U/mg) (PubMed:16759681). It
CC       may also act on ceramide phosphoethanolamine (CPE),
CC       lysophosphatidylcholine (LPC) and lysophosphatidylethanolamine (LPE),
CC       but not on lysophosphatidylserine (LPS), and lysophosphatidylglycerol
CC       (LPG) (By similarity). It acts by transphosphatidylation, releasing
CC       exclusively cyclic phosphate products as second products (By
CC       similarity). Induces dermonecrosis, hemolysis, increased vascular
CC       permeability, edema, inflammatory response, and platelet aggregation
CC       (By similarity). Is lethal to mice (PubMed:16759681).
CC       {ECO:0000250|UniProtKB:A0A0D4WTV1, ECO:0000250|UniProtKB:P0CE80,
CC       ECO:0000269|PubMed:16759681}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=an N-(acyl)-sphingosylphosphocholine = an N-(acyl)-sphingosyl-
CC         1,3-cyclic phosphate + choline; Xref=Rhea:RHEA:60652,
CC         ChEBI:CHEBI:15354, ChEBI:CHEBI:64583, ChEBI:CHEBI:143892;
CC         Evidence={ECO:0000305|PubMed:16759681};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=an N-(acyl)-sphingosylphosphoethanolamine = an N-(acyl)-
CC         sphingosyl-1,3-cyclic phosphate + ethanolamine; Xref=Rhea:RHEA:60648,
CC         ChEBI:CHEBI:57603, ChEBI:CHEBI:143891, ChEBI:CHEBI:143892;
CC         Evidence={ECO:0000250|UniProtKB:A0A0D4WTV1};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1-acyl-sn-glycero-3-phosphocholine = a 1-acyl-sn-glycero-
CC         2,3-cyclic phosphate + choline; Xref=Rhea:RHEA:60700,
CC         ChEBI:CHEBI:15354, ChEBI:CHEBI:58168, ChEBI:CHEBI:143947;
CC         Evidence={ECO:0000250|UniProtKB:A0A0D4WTV1};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1-acyl-sn-glycero-3-phosphoethanolamine = a 1-acyl-sn-
CC         glycero-2,3-cyclic phosphate + ethanolamine; Xref=Rhea:RHEA:60704,
CC         ChEBI:CHEBI:57603, ChEBI:CHEBI:64381, ChEBI:CHEBI:143947;
CC         Evidence={ECO:0000250|UniProtKB:A0A0D4WTV1};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000250|UniProtKB:Q8I914};
CC       Note=Binds 1 Mg(2+) ion per subunit. {ECO:0000250|UniProtKB:Q8I914};
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000305|PubMed:15450925}.
CC   -!- TISSUE SPECIFICITY: Expressed by the venom gland.
CC       {ECO:0000305|PubMed:15450925}.
CC   -!- TOXIC DOSE: LD(50) is 175 ug/kg by intraperitoneal injection into mice.
CC       {ECO:0000269|PubMed:16759681}.
CC   -!- SIMILARITY: Belongs to the arthropod phospholipase D family. Class II
CC       subfamily. Class IIa sub-subfamily. {ECO:0000305}.
CC   -!- CAUTION: The most common activity assay for dermonecrotic toxins
CC       detects enzymatic activity by monitoring choline release from
CC       substrate. Liberation of choline from sphingomyelin (SM) or
CC       lysophosphatidylcholine (LPC) is commonly assumed to result from
CC       substrate hydrolysis, giving either ceramide-1-phosphate (C1P) or
CC       lysophosphatidic acid (LPA), respectively, as a second product.
CC       However, two studies from Lajoie and colleagues (2013 and 2015) report
CC       the observation of exclusive formation of cyclic phosphate products as
CC       second products, resulting from intramolecular transphosphatidylation.
CC       Cyclic phosphates have vastly different biological properties from
CC       their monoester counterparts, and they may be relevant to the pathology
CC       of brown spider envenomation. {ECO:0000250|UniProtKB:A0A0D4WTV1,
CC       ECO:0000250|UniProtKB:A0A0D4WV12, ECO:0000250|UniProtKB:Q4ZFU2}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY559846; AAT66075.1; -; mRNA.
DR   AlphaFoldDB; Q5YD75; -.
DR   SMR; Q5YD75; -.
DR   ArachnoServer; AS000133; Sphingomyelinase D (LrSicTox-alphaIB1).
DR   BRENDA; 3.1.4.41; 3077.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0016829; F:lyase activity; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0008081; F:phosphoric diester hydrolase activity; IEA:InterPro.
DR   GO; GO:0090729; F:toxin activity; IEA:UniProtKB-KW.
DR   GO; GO:0044179; P:hemolysis in another organism; IEA:UniProtKB-KW.
DR   GO; GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW.
DR   Gene3D; 3.20.20.190; -; 1.
DR   InterPro; IPR017946; PLC-like_Pdiesterase_TIM-brl.
DR   SUPFAM; SSF51695; SSF51695; 1.
PE   1: Evidence at protein level;
KW   Cytolysis; Dermonecrotic toxin; Disulfide bond; Hemolysis;
KW   Lipid degradation; Lipid metabolism; Lyase; Magnesium; Metal-binding;
KW   Secreted; Toxin.
FT   CHAIN           1..279
FT                   /note="Dermonecrotic toxin LrSicTox-alphaIB1"
FT                   /id="PRO_0000279581"
FT   ACT_SITE        11
FT                   /evidence="ECO:0000250|UniProtKB:Q8I914"
FT   ACT_SITE        47
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000250|UniProtKB:Q8I914"
FT   BINDING         31
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250|UniProtKB:Q8I914"
FT   BINDING         33
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250|UniProtKB:Q8I914"
FT   BINDING         91
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250|UniProtKB:Q8I914"
FT   DISULFID        51..57
FT                   /evidence="ECO:0000250|UniProtKB:P0CE80"
FT   DISULFID        53..196
FT                   /evidence="ECO:0000250|UniProtKB:P0CE80"
SQ   SEQUENCE   279 AA;  31202 MW;  8619EA9AFA5EEC82 CRC64;
     ANKRPAWIMG HMVNAVAQID EFVNLGANSI ETDVSFDKNA NPEYTYHGIP CDCGRTCTKW
     ENFNDFLKGL RKATTPGDSK YHEKLVLVVF DLKTGSLYDN QAYDAGKKLA KNILQHYWNN
     GNNGGRAYIV LSIPNLAHYK LITGFKETLT SEGHPELMEK VGYDFSGNDD IDKVGNAYKN
     AGVTGHVWQS DGITNCLLRG LSRVKEAVKN RDSSNGFINK VYFWTVDKRA STRDALDAGV
     DGIMTNYPDV IADVLSESAY KANFRIATYD DNPWETFKN
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024